MCM
GMAB icon

Manchester Capital Management’s Genmab GMAB Stock Holding History

Manchester Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.23K Hold
336
– – ﹤0.01% 806
2026
Q1 		$9.02K Sell
336
-30
-8% -$899 ﹤0.01% 805
2025
Q4 		$11.3K Buy
+366
New +$11.4K ﹤0.01% 762
2021
Q3 		– Sell
-122
Closed -$5K – 1066
2021
Q2 		$5K Buy
+122
New +$4.71K ﹤0.01% 570

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Manchester Capital Management's GMAB Position: Q2 2026 in Review

Manchester Capital Management held its Genmab (GMAB) position steady in Q2 2026 at 336 shares worth $9.23K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

Manchester Capital Management first reported a position in GMAB in Q2 2021 and has held it in 4 quarters since. The position peaked at $11.3K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Manchester Capital Management held 336 shares of Genmab worth $9.23K as of Q2 2026.
  • Manchester Capital Management left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #806 holding.
  • Manchester Capital Management first reported a position in Genmab in Q2 2021 and has held it in 4 quarters since.
  • Manchester Capital Management's Genmab position peaked at $11.3K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.